Veracity Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Sell
1,872
-8
-0.4% -$8.17K 0.61% 25
2026
Q1
$1.73M Sell
1,880
-504
-21% -$511K 0.62% 26
2025
Q4
$2.56M Buy
2,384
+7
+0.3% +$6.69K 0.75% 16
2025
Q3
$1.81M Sell
2,377
-63
-3% -$46.9K 0.58% 29
2025
Q2
$1.9M Sell
2,440
-73
-3% -$56.7K 0.65% 23
2025
Q1
$2.08M Sell
2,513
-84
-3% -$69.9K 0.8% 15
2024
Q4
$2.01M Sell
2,597
-655
-20% -$542K 0.72% 20
2024
Q3
$2.88M Buy
3,252
+93
+3% +$83.6K 1.09% 12
2024
Q2
$2.86M Buy
3,159
+10
+0.3% +$8K 1.19% 12
2024
Q1
$2.45M Sell
3,149
-47
-1% -$33.4K 0.95% 16
2023
Q4
$1.86M Buy
3,196
+72
+2% +$42K 0.75% 22
2023
Q3
$1.68M Buy
3,124
+340
+12% +$175K 0.78% 21
2023
Q2
$1.31M Buy
2,784
+378
+16% +$159K 0.55% 34
2023
Q1
$826K Buy
2,406
+21
+0.9% +$7.08K 0.38% 57
2022
Q4
$872K Buy
2,385
+19
+0.8% +$6.74K 0.42% 52
2022
Q3
$765K Sell
2,366
-26
-1% -$8.24K 0.42% 48
2022
Q2
$776K Sell
2,392
-99
-4% -$29.7K 0.41% 57
2022
Q1
$713K Buy
2,491
+27
+1% +$6.95K 0.3% 84
2021
Q4
$681K Sell
2,464
-8
-0.3% -$2.03K 0.27% 92
2021
Q3
$571K Buy
2,472
+30
+1% +$7.4K 0.24% 108
2021
Q2
$561K Sell
2,442
-2,580
-51% -$518K 0.13% 136
2021
Q1
$938K Buy
5,022
+104
+2% +$20.3K 0.2% 128
2020
Q4
$830K Buy
4,918
+202
+4% +$30.2K 0.21% 134
2020
Q3
$698K Buy
4,716
+146
+3% +$22.6K 0.19% 133
2020
Q2
$750K Sell
4,570
-24
-0.5% -$3.68K 0.21% 124
2020
Q1
$637K Sell
4,594
-252
-5% -$34.6K 0.18% 96
2019
Q4
$637K Buy
+4,846
New +$562K 0.16% 114

Other funds holding LLY

Veracity Capital's LLY Position: Q2 2026 in Review

Veracity Capital reduced its Eli Lilly (LLY) stake by 0.43% in Q2 2026, selling an estimated $8.17K and leaving 1,872 shares worth $2.24M. The position accounts for 0.61% of the portfolio, ranked #25.

Veracity Capital first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.88M in Q3 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Veracity Capital held 1,872 shares of Eli Lilly worth $2.24M as of Q2 2026.
  • Veracity Capital sold 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
  • Eli Lilly made up 0.61% of Veracity Capital's portfolio in Q2 2026, its #25 holding.
  • Veracity Capital first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • Veracity Capital's Eli Lilly position peaked at $2.88M in Q3 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Veracity Capital's 13F filing for Q2 2026, filed 13 Jul 2026.